News

Gonioscopy-assisted transluminal trabeculotomy is a circumferential trabeculotomy performed via a minimally invasive, ab interno approach. Results from follow-up of 6 to 12 months in a series of 85 adult eyes with uncontrolled glaucoma show high IOP lowering, along with a reduced need for medication.

The AREDS 1 and 2 studies provide important information about the role of ocular nutrition in AMD. However, to benefit patients, the findings must be condensed into clear and concise advice that will help them select appropriate vitamin supplements and follow a healthy lifestyle.

A randomized, double blind study of physicians who took part in the Physicians’ Health Study II found that those who received a daily multivitamin had a 9% lower risk of cataract - and a 14% lower risk of nuclear cataract- than those who received placebo. Given the prevalence of cataracts in the population at large, a 9% reduction in risk could have a significant public health impact.

Examining how nutrition affects vision, and how physicians need to encourage healthy diets that contain essential nutrients and antioxidants essential for healthy vision.

Primary outcome data from a phase III clinical trial evaluating aflibercept (Eylea, Regeneron) for macular edema (ME) due to branch retinal vein occlusion (BRVO) show that intravitreal treatment with the anti-VEGF agent was well tolerated and associated with significantly better improvements in visual acuity and central retinal thickness (CRT) than laser photocoagulation.

Novaliq GmbH has announced the commencement of a phase I study for its dry eye syndrome treatment, cyclosporine solution (CyclASol), following United States and European patent approval.

BioLight Israeli Life Sciences Investments’ subsidiary, ViSci, has filed an investigational new drug (IND) application with the FDA to conduct a phase I/IIa clinical study with its treatment for glaucoma-a subconjunctival Latanoprost controlled-release insert.

Congress has approved legislation delaying for 1 year a massive 24% Medicare fee cut, which had been scheduled to take effect April 1, as well as implementation of the ICD-10-CM coding system.

A new optical coherence tomography (OCT)-based method for IOL power selection has been found to be a promising method for achieving good refractive outcomes when performing cataract surgery in eyes with a history of laser vision correction, according to analyses of data from a retrospective comparative case series.

The FDA has granted 510(k) clearance to Bausch + Lomb’s comprehensive surgical platform-the Stellaris PC Vision Enhancement System-for the integrated 523-nm laser and software.

Alimera Sciences has resubmitted its New Drug Application (NDA) for its fluocinolone acetonide intravitreal implant (Iluvien) to the FDA.

Ophthalmic Women Leaders (OWL) has announced it will honor three award winners during its signature “OWL Monday” reception and program held in conjunction with the American Society of Cataract and Refractive Surgery meeting in Boston.

This month’s simultaneous meeting of the American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators will convene in Boston from April 25 to 29.

An array of IOLs under development and in clinical trials show promise for correcting presbyopia or addressing other limitations of existing pseudophakic lenses.

New tools for pediatric glaucoma surgery are becoming available that improve the ability to examine pediatric patients, perform surgeries more easily, and enhance treatment of difficult cases.